Artificial Medical Intelligence Announces Version 4.0 of its Computer Assisted Coding Software
* Reuters is not responsible for the content in this press release.
Most Extensive, Feature-Rich Solution for Hospital Coding, Health Information Management and Finance EATONTOWN, N.J.--(Business Wire)-- Artificial Medical Intelligence (AMI) today announced its newly enhanced EMscribe Computer Assisted Coding (CAC) software, version 4.0. EMscribe software utilizes AMI`s patented Natural Language Processing Coding technology to read patient records for appropriate ICD9-CM diagnostic, procedure and CPT codes. It then pre-codes the records and presents them for coder review. Manual coders enhanced with the results of EMscribe can easily approve or amend the automatic results and increase efficiencies by as much as 80%. Version 4.0 incorporates new groundbreaking features such as Running DRG Analysis, ChargeMaster Integration, Scanned Document Annotation with Manipulation, Automated Supervisor Code Audit Flagging and Enhanced Hybrid Medical Record Processing. By harnessing the power of Version 4.0`s extensive abstraction capability, hospitals can now use EMscribe to better manage coder workflow while tapping into extensive HIM and Finance reporting tools. Version 4.0 now offers a choice of either MSSQL or MySQL databases so that hospital IT staff can have better control over the valuable data derived through EMscribe`s language processing technology. EMscribe can be customized for each hospital`s unique coding guidelines. With EMscribe`s new Codeamatic feature, hospital coding departments can tune the EMscribe engine to be in line with each hospital site`s special coding rules. Codeamatic customization can be as subtle as tuning for dynamic acronyms that staff physicians may dictate or as general as incorporating basic guidelines as the suppression of a group or procedure. Real automation techniques in Version 4.0 now make it possible to process without human intervention certain approved record types such as ancillary radiology and lab records. This functionality significantly increases productivity and eliminates many mundane coding tasks that bog down and delay the hospital bill process. Version 4.0 is also ICD10 ready and is prepared for any future coding convention mandates. "AMI`s main mission is to provide healthcare organizations with flexible, adaptive, and comprehensive technology designed to support current and future hospital workflows," said Stuart Covit, executive VP of AMI. "Our new enhancements support this goal and our customers applaud us as they continue to see dramatic improvements in efficiency and money saving advantages." EMscribe was first commercially live at Robert Wood Johnson University Hospital in 2005 and now has significant market penetration. About AMI (www.artificialmed.com) Founded in 2002, Artificial Medical Intelligence is a healthcare informatics software developer focusing on increasing efficiency within Health Information Management. Its patented core solution, EMscribe, provides suggested ICD9-CM and CPT codes for both the inpatient and outpatient encounter. The innovative solution also functions as an information abstraction engine automating such values as Present on Admission, Hospital Acquired Condition and drug abstractions, thus making it the most comprehensive hospital tested HIM-Coding solution available. AMI`s solutions are targeted at hospital healthcare facilities, larger clinics and physician practices that are looking to automate process management and improve the processing of medical documents. The Powered by EMscribeTM technology is available to partners and is sold directly to hospitals nationwide and through the Dolbey distribution channel. The company is headquartered in Eatontown, New Jersey. For further information or to arrange for interviews, please contact: Artificial Medical Intelligence Stuart Covit, 866-415-6112 scovit@artificialmed.com or Results Public Relations Elyse Familant, 978-725-3637 elysef@resultspr.net Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.



Follow Reuters